Metronidazole Flashcards
Metronidazole is bactericidal/bacteriostatic
bactericidal
Metronidazole structure
nitroimidazole, heterocyclic; imidazole based nucleus with a nitro group
Metronidazole MOA
- drug enters bacterial cell by passive diffusion
- electron is transferred to the nitro group of metronidazole and results in production of short-lived nitroso free radical, which is cytotoxic and can interact with cellular DNA
- produces cytotoxic effect of reduced product because the activated metronidazole compound can inhibit DNA synthesis and induce DNA damage via oxidation, resulting in single-strand double-straw breaks
- induces DNA degradation and cell death. finally there is the release of inactive end products of the drug.
Metronidazole is activated in _____ when it recipes an electron from ____ or ____
anaerobic bacteria; ferredoxin; flavodoxin
Aerobic bacteria are _____ to activate prodrug because
unable; they lack necessary electron transport proteins with sufficient negative redox potential
Metronidazole spectrum coverage
ANAEROBES ONLY
light purple: prevotella
dark red: bacteroides, clostridium
light red: fusobacterium
Metronidazole is available in these formulations:
oral capsules, tablets, IV solution, topical gels, creams, lotions and vaginal gels
Metronidazole needs/does not need renal adjustment t
does not
When should metronidazole be adjusted for hepatic impairment?
severe hepatic impairment; give 50% dose
Metronidazole oral absorption
really good 98-100%
Metronidazole 1/2 life
8 hours; long
Metronidazole is ____protein bound
<20%
Metronidazole volume of distribution
adult: 0.55 L/kg
neonatesL 0.54-0.81 L/kg
Metronidazole is metabolized by
oxidation, glucoronidation, by CYPs and yield 5 major metabolites which are excreted in the urine and feces
Metronidazole indications
Parasitic infections: trichomonas vaginalis, giardia, entamoeba histolytica
anaerobic infections: brain abscess, gynelogic, bacteremia, bone and joint, respiratory, intra-ab, lung abscess/nectrotizing pneumonia
C. diff: no longer recommended by IDSA as first line treatment for mild infections due to concern for failure
H.pylori: increasing resistance, part of a combo of 3-4 drugs